ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Cyclo(His-Pro) Prevents Against Renal Injury Through Activating Nrf2-Mediated Pathway

    J. Moon1, Y. Kim1, H. Jung2, J. Kim1, W. Ju3, H. Lee1, J. Lee4, C. Lee5, D. Kim1, Y. Kim1, S. Yang6

    1Seoul National University Hospital, Seoul, Korea, Republic of, 2R&D Center, NovMetaPharma Co., Ltd, Pohang, Gyeongbuk, Korea, Republic of, 3Seoul National University Biomedical Research Institute, Seoul, Korea, Republic of, 4Nephrology Clinic, National Cancer Center, Goyang, Korea, Republic of, 5Cheju Halla General Hospital, Jeju-do, Korea, Republic of, 6Kidney Research Institute, Seoul National University College of Medicine, Seoul, Korea, Republic of

    *Purpose: Cyclic(His-Pro) (CHP) is an endogenous cyclic dipeptide that has antioxidative, anti-inflammatory effect via Nuclear factor erythroid 2-related factor (Nrf2) pathway. Endogenous CHP is distributed…
  • 2020 American Transplant Congress

    Alemtuzumab and Associated Infectious and Transplant Outcomes in Renal Re-Transplant Patients

    T. N. Harris

    The Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC

    *Purpose: The purpose of this study was to evaluate infectious and transplant outcomes exclusively in renal re-transplant patients who had received alemtuzumab for induction therapy.*Methods:…
  • 2020 American Transplant Congress

    Differences in Alemtuzumab Dosing Does Not Affect Early Kidney Transplant Outcomes

    A. Pressley, R. Stratta, J. Rogers, A. Farney, G. Orlando, W. Doares, A. Reeves-Daniel, C. Jay

    Wake Forest Baptist Health, Winston-Salem, NC

    *Purpose: Alemtuzumab (Alem) is a widely used medication for induction therapy in kidney transplantation. However, there is limited evidence comparing outcomes with low versus high…
  • 2020 American Transplant Congress

    Ethical and Financial Consequences of Incidental Radiological Findings During Living Kidney Donor Evaluation

    R. Mao, R. Kulkarni, C. Duran, H. Stevenson-Lerner, M. Mujtaba, J. Fair, M. Kueht

    University of Texas Medical Branch, Galveston, TX

    *Purpose: Living kidney donation (LKD) provides a unique situation in that diagnostic studies are ordered on a presumably healthy individual. Literature has shown that preoperative…
  • 2020 American Transplant Congress

    The Association between Timed-Up-and-Go Test and Montreal Cognitive Assessment on Outcomes of Renal Transplant Candidates

    K. Bozhilov, L. Wong

    Transplant Surgery, Queens Medical Center, Honolulu, HI

    *Purpose: Patients with frailty who undergo renal transplantation (RT) have a higher incidence of delayed graft function and rehospitalization, however little is known about the…
  • 2020 American Transplant Congress

    Long-Term Outcomes for the Use of Native Small Capacity, Defunctionalized Bladders in Pediatric Kidney Transplantation

    P. Vuong, A. Brubaker, L. Maestretti, W. Concepcion, A. Gallo

    Stanford University Medical Center, Palo Alto, CA

    *Purpose: Small capacity, defunctionalized urinary bladders present a challenge in pediatric kidney transplantation due to the inability to perform an adequate anti-reflux ureterocystostomy in a…
  • 2020 American Transplant Congress

    Early Impact of Interleukin-6 Blockade on the Distribution of Peripheral Blood Immune Cell Subpopulations – 3-Month Results of a Phase 2 Trial Evaluating Clazakizumab in Late Antibody-Mediated Rejection

    K. A. Doberer1, G. A. Boehmig1, M. Streitz2, S. Schlickeiser2, F. Bauernfeind1, A. Spittler3, B. Jilma4, F. Eskandary1, E. Chong5, S. Schranz4, K. Budde6, M. Dürr6

    1Department of Medicine III, Medical University of Vienna, Vienna, Austria, 2Charité Universitätsmedizin Berlin, Institute of Medical Immunology, Berlin, Germany, 3Center of Translational Research, Medical University of Vienna, Vienna, Austria, 4Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria, 5Vitaeris Inc., Vancouver, BC, Canada, 6Division of Nephrology and Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany

    *Purpose: Interleukin-6 (IL-6) is considered to play a critical role within the multifacted pathophysiological process of antibody-mediated rejection (ABMR), including modulation of regulatory T cells…
  • 2020 American Transplant Congress

    A Single Nucleotide Polymorphism of Tweak Predicts Arterio- and Arteriolohyalinosis in Kidney Transplants and is Associated with Allograft Survival

    A. Karolin1, D. Thottan1, J. Zinsli1, S. Rudloff1, U. Huynh-Do1, V. Banz2, T. Berney3, M. Pascual4, T. Müller5, P. d’Amico6, I. Binet7, D. Sidler1

    1Nephrology and Hypertension, University Bern, Bern, Switzerland, 2University Bern, Bern, Switzerland, 3University Hospital Genevia, Genevia, Switzerland, 4University Hospital Lausanne, Lausanne, Switzerland, 5University Hospital Zurich, Zurich, Switzerland, 6Hospital St.Gallen, St.Gallen, Switzerland, 7University Hospital Basel, Basel, Switzerland

    *Purpose: We have recently demonstrated that the TNF superfamily member is critical for the pathogenesis of Calcineurin Inhibitor Toxicity (CNT). CNT is a common side…
  • 2020 American Transplant Congress

    Late Conversion from Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters

    J. Noble, F. Terrec, T. Jouve, H. Neciri Bennani, P. Benhamou, P. Malvezzi, B. Janbon, D. Giovannini, L. Rostaing

    Nephrology and Transplant Unit, CHU Grenoble, Grenoble, France

    *Purpose: Calcineurin inhibitors (CNIs) and steroids are strongly associated with new-onset diabetes after transplantation (NODAT), worsening of pre-existing diabetes, and cardiovascular events. We assessed the…
  • 2020 American Transplant Congress

    The Link between Waitlist Mortality and Access to Transplant, an Imaginative Reality

    R. Batra1, D. Mulligan1, D. Haakinson1, S. Noreen2, D. Stewart2, G. Gan3, Y. Deng3, S. Kulkarni1

    1Surgery, Yale University School of Medicine, New Haven, CT, 2UNOS, Richmond, VA, 3Yale University, New Haven, CT

    *Purpose: Liver transplant waitlist mortality due to inadequate access to livers is the Achilles heel in liver transplantation in United States. This remains amongst the…
  • « Previous Page
  • 1
  • …
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 223
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences